NCT01482182View on ClinicalTrials.gov

Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

January 31, 2014

Conditions
Non-small Cell Lung Cancer
Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

Guerbet
All Listed Sponsors
collaborator

Guerbet

INDUSTRY

lead

Samsung Medical Center

OTHER

NCT01482182 - Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy | Biotech Hunter | Biotech Hunter